PLAIN LANGUAGE SUMMARY Health Technology Assessment (HTA) is an evidence-based decision-making process, focusing on evaluating health technologies for funding within a healthcare system. 'Health technologies' include medications, medical devices, diagnostics, medical procedures and services. Health Technology Assessment international (HTAi) is a global society for those who produce, use, participate in, or encounter HTA. The HTAi Secretariat supports special interest groups within HTAi. One such special interest group, the Patient and Citizen Involvement in HTA Interest Group (PCIG), focuses on strengthening patient involvement in HTA. PCIG's members are from HTA agencies, research, industry, and patient organisations. We describe the steps PCIG has taken to form an international panel of patient advocates (the Patient Panel) as an autonomous group within its governance structure that reports directly to the PCIG Steering Committee. The Patient Panel was established in order to strengthen meaningful patient involvement in HTA by working co-productively with other PCIG members to develop resources accessible to patient organisations. Patient advocates known to be active within HTA in their own countries were invited to form the inaugural group, with one person appointed to chair the group for the first year. Documentation had been prepared to inform potential members and set out potential roles as seen by the Steering Committee. The appointed Patient Panel is defining its own terms of reference, goals and objectives. The Panel Chair is a member of the PCIG Steering Committee, and is mentored by the retiring PCIG chair. A registry of activities is part of monitoring and evaluation. ABSTRACT Background Health Technology Assessment (HTA) is an evidence-based decision-making process, focusing on evaluating health technologies for funding within a healthcare system or medical insurance system. 'Health technologies' are understood broadly, and include medications, medical devices, diagnostics, medical procedures and services. Health Technology Assessment international (HTAi) is a global society for those who produce, use, participate in, or encounter HTA. The HTAi Secretariat supports special interest groups within HTAi, including the Patient and Citizen Involvement in HTA Interest Group (PCIG), which focuses on strengthening patient involvement in HTA. PCIG's members come from HTA agencies, research, industry, and patient organisations. Main body We describe the steps the PCIG has taken to form an international panel of patient advocates as an autonomous group within its governance structure, reporting directly to the PCIG Steering Committee. Patient advocates known to be active within HTA in their own countries were invited to form the inaugural group. One person was invited to chair the Panel for the first year of its operation, based on the candidate's experience of working across diseases and countries, and being new to HTAi. Documentation was prepared to inform potential members of the Panel and set out potential roles as seen by the Steering Committee. The Panel came into being in March 2016 and is now setting out its own working principles, goals and objectives. The Panel Chair is a member of the PCIG Steering Committee, and is mentored by the previous PCIG chair. A registry of activities has been set up as part of monitoring and evaluation. The Patient Panel is intended to provide a focus within the PCIG for patient advocates to work among themselves and co-productively through the PCIG Working Groups to develop mutual understanding and strengthen meaningful patient involvement in HTA internationally. Patient advocates can benefit from a clear understanding the evidence requirements within HTA and how information can be effectively presented by patient groups to decision-making bodies. Conclusion The HTAi Patient and Citizen Involvement Interest Group has set up a Patient Panel consisting of patient advocates. The intent is to work co-productively to advance patient involvement in HTA.

中文翻译：

---

在 HTAi 患者和公民参与兴趣小组中加强国际患者对患者参与 HTA 的倡导观点 - 评论。


通俗语言摘要 卫生技术评估 (HTA) 是一个基于证据的决策过程，重点是评估卫生技术以在医疗保健系统内提供资金。 “健康技术”包括药物、医疗设备、诊断、医疗程序和服务。国际卫生技术评估 (HTAi) 是一个为那些生产、使用、参与或接触 HTA 的人设立的全球性协会。 HTAi 秘书处支持 HTAi 内的特殊利益团体。 HTA 患者和公民参与兴趣小组 (PCIG) 就是这样一个特殊兴趣小组，其重点是加强患者对 HTA 的参与。 PCIG 的成员来自 HTA 机构、研究、行业和患者组织。我们描述了 PCIG 为组建国际患者倡导者小组（患者小组）所采取的步骤，将其作为其治理结构内的一个自治团体，直接向 PCIG 指导委员会报告。患者小组的成立是为了通过与其他 PCIG 成员共同开发患者组织可用的资源，加强患者对 HTA 的有意义的参与。已知在本国 HTA 中活跃的患者权益倡导者被邀请组成首届小组，并任命一人担任该小组第一年的主席。已准备好文件以告知潜在成员并列出指导委员会认为的潜在角色。指定的患者小组正在制定自己的职权范围、目的和目标。小组主席是 PCIG 指导委员会的成员，并接受即将退休的 PCIG 主席的指导。活动登记是监测和评估的一部分。 摘要 背景 卫生技术评估 (HTA) 是一个基于证据的决策过程，重点评估卫生技术以在医疗保健系统或医疗保险系统内提供资金。 “健康技术”的理解很广泛，包括药物、医疗设备、诊断、医疗程序和服务。国际卫生技术评估 (HTAi) 是一个为那些生产、使用、参与或接触 HTA 的人设立的全球性协会。 HTAi 秘书处支持 HTAi 内的特殊利益团体，包括 HTA 患者和公民参与兴趣小组 (PCIG)，其重点是加强患者对 HTA 的参与。 PCIG 的成员来自 HTA 机构、研究、行业和患者组织。主体 我们描述了 PCIG 为组建国际患者倡导小组作为其治理结构内的自治团体而采取的步骤，直接向 PCIG 指导委员会报告。已知在本国 HTA 中活跃的患者权益倡导者受邀组成首届小组。根据候选人跨疾病和跨国家工作的经验以及 HTAi 的新手经验，一名候选人被邀请担任该小组运作第一年的主席。已准备好文件，以告知该小组的潜在成员，并列出指导委员会认为的潜在角色。该小组于 2016 年 3 月成立，目前正在制定自己的工作原则、目标和目标。小组主席是 PCIG 指导委员会的成员，并接受前任 PCIG 主席的指导。作为监测和评估的一部分，已经建立了活动登记册。 患者小组旨在在 PCIG 内为患者倡导者提供一个重点，让他们相互合作并通过 PCIG 工作组共同开展工作，以增进相互理解并加强患者在国际上对 HTA 的有意义的参与。患者权益倡导者可以从清楚地了解 HTA 内的证据要求以及患者团体如何有效地向决策机构提供信息中受益。结论 HTAi 患者和公民参与兴趣小组成立了由患者倡导者组成的患者小组。目的是共同努力促进患者参与 HTA。